18 results
8-K
EX-99.1
NGM
Ngm Biopharmaceuticals Inc
4 Apr 23
Cost Associated with Exit or Disposal Activities
4:06pm
-Long has built a scientific leadership team more than capable of continuing our track record of innovation. With Jin-Long’s departure, I am pleased
8-K
EX-99.1
NGM
Ngm Biopharmaceuticals Inc
12 Nov 20
NGM Bio Provides Business Highlights and Reports Third Quarter 2020 Financial Results
4:32pm
but also highlight the talented NGM scientists whose expertise, creativity and passion have enabled our track record of rapid innovation and sustained
10-K
7gdn7mp42rgz9q52d
17 Mar 20
Annual report
4:33pm
S-1/A
l10lqwj2 400dk
25 Mar 19
IPO registration (amended)
12:00am
S-1
u3lyxsa
28 Sep 18
IPO registration
5:14pm
424B1
e6ixo1i90s2j3
4 Apr 19
Prospectus with pricing info
5:21pm
DRS
7u71xe0jmr25pam1hn
10 Aug 18
Draft registration statement
12:00am
S-1
EX-10.15
1nn33jxbnd4rbqi4
28 Sep 18
IPO registration
5:14pm
DRS
EX-10.15
7wqs9 vm9sss4xiogh
10 Aug 18
Draft registration statement
12:00am
- Prev
- 1
- Next